Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Annals of Hematology|January 27, 2024
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601Kazuyuki Shimada, Ken Ohmachi, Ryunosuke Machida, et al.International Journal of Hematology|June 14, 2022
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myelomaSatsuki Murakami, Masaki Ri, Masato Ito, et al.Hematological Oncology|September 26, 2020
Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphomaKatsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki, et al.The Oncologist|April 15, 2017
A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell LymphomaKatsuhiro Miura, Jun Konishi, Takaaki Miyake, et al.British Journal of Haematology|August 11, 2021
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohortTatsuzo Mishina, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, et al.British Journal of Haematology|June 26, 2020
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, et al.Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.Cancer Chemotherapy and Pharmacology|January 24, 2025
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1)Masaki Ri, Shinsuke Iida, Kosuke Saito, et al.Cancer Science|August 9, 2020
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 studyYoshitoyo Kagami, Kazuhito Yamamoto, Taro Shibata, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2015
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational StudyShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.Pageof 5